ATAI Life Sciences N.V. (ATAI) Fundamentals

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
SHARE INFORMATION
Market CapUS$ 617,213,894
Shares Outstanding160,732,785
Float126,708,007
Percent Float78.83%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 20,376,000
Latest Fiscal EPSUS$ -1.20
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions154
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months2,190,799
Institutional Holdings Percent14.0%
Institutional Sold Previous 3 Months612,073
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months6,417,296
Insider Holdings Percent0.0
Insider Sold Previous 3 Months5,559,808
Insider Shares Owned23,330
TRADING INFO
52 Week HighUS$ 22.91
52 Week LowUS$ 3.05
52 Week High ChangeUS$ 0.00
21 Day Moving AverageUS$ 3.9438
21 Day Extended Moving AverageUS$ 4.0276
50 Day Moving AverageUS$ 4.6303
50 Day Extended Moving AverageUS$ 4.5645
200 Day Moving AverageUS$ 9.2996
200 Day Extended Moving AverageUS$ 8.3392
10 Day Average Volume785,595
20 Day Average Volume892,992
30 Day Average Volume830,889
50 Day Average Volume873,698
Alpha-0.125135
Beta0.4392
Standard Deviation0.136673
R20.026459
7 Day Price ChangeUS$ -0.08
7 Day Percent Change-2.04%
21 Day Price ChangeUS$ -0.54
21 Day Percent Change-12.33%
30 Day Price ChangeUS$ -1.13
30 Day Percent Change-22.74%
Month to Date Price ChangeUS$ -0.45
Month to Date Percent Change-10.49%
Quarter to Date Price ChangeUS$ -1.25
Quarter to Date Percent Change-24.56%
180 Day Price ChangeUS$ -7.47
180 Day Percent Change-66.05%
200 Day Price ChangeUS$ -13.34
200 Day Percent Change-77.65%
Year to Date Price ChangeUS$ -3.79
Year to Date Percent Change-49.67%

ATAI Life Sciences N.V. (ATAI) Key Ratios

PROFITABILITY
EBIT Margin-32,013.9%
EBITDA Margin-31,993.5%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 496,000
Revenue Per ShareUS$ 0.0031
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.80
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio15.80
Leverage Ratio1.10
Quick Ratio15.50
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-2.60
Enterprise ValueUS$ 271,773,599
Price to Sales1,244.3828
Price to Free Cash-4.90
PE High Last 5 Years0.00
Price To Book1.80
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.20
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-78.85
Return on Equity-91.03
Return on Capital-89.44

ATAI Life Sciences N.V. (ATAI) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorDeloitte & Touche LLP
CEOFlorian Brand
Emplyoees87
Last AuditUQ
CIK0001840904
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Addressc/o Mindspace
Krausenstrasse 9-10
Berlin, BB 10117
Websitehttps://www.atai.life
Facsimile-
Telephone+49 8921539035
Email-
Your Recent History
NASDAQ
ATAI
ATAI Life ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20220526 00:59:49